Retinal cases & brief reports · 2025
LASER PHOTOCOAGULATION TREATMENT FOR CANDIDA CHORIORETINITIS.
СтатьяКлинический случайНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Su Robin C, Mehra Ankur, Chiang Tsun-Kang, Seraly Mark, Kurup Shree
Аннотация
PURPOSE: The purpose of this article is to describe the novel surgical technique using laser photocoagulation for the management of Candida chorioretinal lesions that are refractory to medical therapy.
METHODS: This report presents the use of laser photocoagulation applied to a Candida chorioretinal lesion that was refractory to extensive systemic and intravitreal antifungal medications. The presenting lesion was in an immunosuppressed patient. Argon laser photocoagulation was applied onto and surrounding the Candida chorioretinal lesion.
RESULTS: After laser photocoagulation, the Candida chorioretinal lesion has remained resolved for more than 1 year with no further reactivation, extensions, or satellites.
CONCLUSION: Candida chorioretinitis can be extremely therapeutically resistant. Current treatment involves systemic and intravitreal antifungals. There are currently limited options for chorioretinal lesions refractory to standard medical therapy. The authors report the novel application of laser photocoagulation as a potential treatment option in refractory cases of Candida chorioretinitis.
METHODS: This report presents the use of laser photocoagulation applied to a Candida chorioretinal lesion that was refractory to extensive systemic and intravitreal antifungal medications. The presenting lesion was in an immunosuppressed patient. Argon laser photocoagulation was applied onto and surrounding the Candida chorioretinal lesion.
RESULTS: After laser photocoagulation, the Candida chorioretinal lesion has remained resolved for more than 1 year with no further reactivation, extensions, or satellites.
CONCLUSION: Candida chorioretinitis can be extremely therapeutically resistant. Current treatment involves systemic and intravitreal antifungals. There are currently limited options for chorioretinal lesions refractory to standard medical therapy. The authors report the novel application of laser photocoagulation as a potential treatment option in refractory cases of Candida chorioretinitis.